Congenital hypothyroidism medical therapy: Difference between revisions
Created page with "__NOTOC__ {{Congenital hypothyroidism}} {{CMG}} ==Overview== ==Medical Therapy== The goal of newborn screening programs is to detect and start treatment within the first 1..." |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Congenital hypothyroidism}} | {{Congenital hypothyroidism}} | ||
{{CMG}} | {{CMG}}; {{AE}} | ||
{{PleaseHelp}} | |||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
The goal of newborn [[screening]] programs is to detect and start treatment within the first 1-2 weeks of life. Treatment consists of a daily dose of [[thyroxine]], available as a small tablet. The generic name is [[levothyroxine]], and several brands are available. Commonly used brands in North America are Synthroid, Levoxyl, Unithroid, and Levothroid. The tablet is crushed and given to the infant with a small amount of water or milk. The most commonly recommended dose range is 10-15 μg/kg daily, typically 37.5 or 44 μg.<ref>Journal of Pediatric Endocinology and Metabolism 20:559 '''PMID 17642417'''</ref> | The goal of newborn [[screening]] programs is to detect and start treatment within the first 1-2 weeks of life. Treatment consists of a daily dose of [[thyroxine]], available as a small tablet. The generic name is [[levothyroxine]], and several brands are available. Commonly used brands in North America are Synthroid, Levoxyl, Unithroid, and Levothroid. The tablet is crushed and given to the infant with a small amount of water or milk. The most commonly recommended dose range is 10-15 μg/kg daily, typically 37.5 or 44 μg.<ref>Journal of Pediatric Endocinology and Metabolism 20:559 '''PMID 17642417'''</ref> | ||
Within a few weeks, the T<sub>4</sub> and TSH levels are rechecked to confirm that they are being normalized by treatment. As the child grows up, these levels are checked regularly to maintain the right dose. The dose increases as the child grows. | Within a few weeks, the T<sub>4</sub> and TSH levels are rechecked to confirm that they are being normalized by treatment. As the child grows up, these levels are checked regularly to maintain the right dose. The dose increases as the child grows. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 16:08, 22 July 2016
|
Congenital hypothyroidism Microchapters |
|
Differentiating Congenital hypothyroidism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Congenital hypothyroidism medical therapy On the Web |
|
American Roentgen Ray Society Images of Congenital hypothyroidism medical therapy |
|
Risk calculators and risk factors for Congenital hypothyroidism medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Medical Therapy
The goal of newborn screening programs is to detect and start treatment within the first 1-2 weeks of life. Treatment consists of a daily dose of thyroxine, available as a small tablet. The generic name is levothyroxine, and several brands are available. Commonly used brands in North America are Synthroid, Levoxyl, Unithroid, and Levothroid. The tablet is crushed and given to the infant with a small amount of water or milk. The most commonly recommended dose range is 10-15 μg/kg daily, typically 37.5 or 44 μg.[1]
Within a few weeks, the T4 and TSH levels are rechecked to confirm that they are being normalized by treatment. As the child grows up, these levels are checked regularly to maintain the right dose. The dose increases as the child grows.
References
- ↑ Journal of Pediatric Endocinology and Metabolism 20:559 PMID 17642417